Latest Market Research Reports

  U.S. Stem Cells Market Summary The  U.S. stem cells market  size was valued at USD 5.46 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 9.46% from 2024 to 2030. The market growth is supported by the rising acceptance of regenerative medicine, along with an increasing number of regulatory approvals for stem cell therapies. The growing demand for regenerative treatments, coupled with rising healthcare expenditure, has further strengthened market prospects. Additionally, the increasing prevalence of genetic disorders and cancer has generated significant demand for innovative therapies. Moreover, stem cell preservation for future medical use, facilitated through public and private umbilical cord and tissue banking, has proven to be highly beneficial and continues to gain strong acceptance, thereby adding momentum to the market expansion. In 2023, the U.S. accounted for more than 32.4% of the global stem cells market. The region’s domina...

  U.S. Stem Cells Industry The U.S. stem cells market size was estimated at USD 4.79 billion in 2023 and is expected to grow at a CAGR of 9.5% from 2024 to 2030. Increase in acceptance of regenerative medicine and rise in number of regulatory approvals of stem cell therapies are expected to drive the market. Growing demand for regenerative medicines, increase in healthcare expenditure, an increase in the incidence of genetic disorder and cancer are the major factors driving the market. Moreover, preservation of stem cells for future treatment with the help of public & private umbilical cord & tissue banking has proved to be profitable in the past; this practice has already gained immense acceptance offering significant momentum to the stem cells market. The U.S. accounted for over 32.4% of the global stem cells market in 2023. The market is anticipated to be propelled by the escalating progress in precision medicine, the expansion of cell therapy production facilities, and ...